Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Synergistic effects of atorvastatin and all-trans retinoic acid in ameliorating animal model of multiple sclerosis.
Clinical and Magnetic Resonance Imaging (MRI) Distinctions Between Tumefactive Demyelination and Brain Tumors in Children.
Effect of treadmill training on fatigue in multiple sclerosis: a pilot study.
Risperidone-Induced Pisa Syndrome in MS: Resolution with Lurasidone and Recurrence with Chlorpromazine.
Protective Autoimmunity: A Unifying Model for the Immune Network Involved in CNS Repair.
Efficacy of statins in combination with interferon therapy in multiple sclerosis: A meta-analysis.
Disease-modifying drugs for multiple sclerosis in pregnancy: A systematic review.
Poly(ADP-ribose) polymerase 2 contributes to neuroinflammation and neurological dysfunction in mouse experimental autoimmune encephalomyelitis.
The TIM-3 pathway ameliorates Theiler's murine encephalomyelitis virus-induced demyelinating disease.
Multiple sclerosis update.
Insights into multiple sclerosis provided by non-coding RNAs: meeting summary from the symposium 'Non-coding RNAs in autoimmune disorders of the central nervous system' on 5 April 2013 in Warsaw, Poland.
Biomarker time out.
Shared environmental effects on multiple sclerosis susceptibility: conflicting evidence from twin studies.
The node of Ranvier in CNS pathology.
Pathogenesis of immune-mediated neuropathies.
Evaluation of Retinoids for Induction of the Redundant Gene ABCD2 as an Alternative Treatment Option in X-Linked Adrenoleukodystrophy.
TDP6, a brain-derived neurotrophic factor-based trkB peptide mimetic, promotes oligodendrocyte myelination.
Quality of life in multiple sclerosis (MS) and role of fatigue, depression, anxiety, and stress: A bicenter study from north of Iran.
Core muscle strength and endurance measures in ambulatory persons with multiple sclerosis: validity and reliability.
Polysialic acid as an antigen for monoclonal antibody HIgM12 to treat multiple sclerosis and other neurodegenerative disorders.
The many roads to mitochondrial dysfunction in neuroimmune and neuropsychiatric disorders.
STAT4 controls GM-CSF production by both Th1 and Th17 cells during EAE.
JC virus-iLOV fluorescent strains enable the detection of early and late viral protein expression.
Biopsy Proven Tumefactive Multiple Sclerosis with Concomitant Glioma: Case Report and Review of the Literature.
Multicontrast MRI Quantification of Focal Inflammation and Degeneration in Multiple Sclerosis.
Pages
« first
‹ previous
…
475
476
477
478
479
480
481
482
483
…
next ›
last »